| CVSS Meta Temp Score | Current Exploit Price (≈) | CTI Interest Score |
|---|---|---|
| 5.2 | $0-$5k | 0.00 |
Summary
A vulnerability marked as problematic has been reported in IBM Connections up to 5.0 CR3/5.5. Affected by this vulnerability is an unknown functionality of the component Web UI. The manipulation leads to cross site scripting. This vulnerability is referenced as CVE-2016-2954. Remote exploitation of the attack is possible. No exploit is available. It is suggested to install a patch to address this issue.
Details
A vulnerability was found in IBM Connections up to 5.0 CR3/5.5 (Groupware Software). It has been rated as problematic. This issue affects an unknown code of the component Web UI. The manipulation with an unknown input leads to a cross site scripting vulnerability. Using CWE to declare the problem leads to CWE-79. The product does not neutralize or incorrectly neutralizes user-controllable input before it is placed in output that is used as a web page that is served to other users. Impacted is confidentiality, and integrity. The summary by CVE is:
Cross-site scripting (XSS) vulnerability in the Web UI in IBM Connections 5.0 before CR4 and 5.5 before CR1 allows remote authenticated users to inject arbitrary web script or HTML via unspecified vectors, a different vulnerability than CVE-2016-2956 and CVE-2016-3008.
The weakness was published 09/01/2016 (Website). The advisory is shared at www-01.ibm.com. The identification of this vulnerability is CVE-2016-2954 since 03/09/2016. The exploitation is known to be easy. The attack may be initiated remotely. A simple authentication is needed for exploitation. It demands that the victim is doing some kind of user interaction. Neither technical details nor an exploit are publicly available. MITRE ATT&CK project uses the attack technique T1059.007 for this issue.
Applying the patch 5.0 CR4/5.5 CR1 is able to eliminate this problem.
The vulnerability is also documented in the vulnerability database at SecurityFocus (BID 92543†). Similar entries are available at VDB-91026 and VDB-91031. Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
Product
Type
Vendor
Name
Version
License
Website
- Vendor: https://www.ibm.com/
CPE 2.3
CPE 2.2
CVSSv4
VulDB Vector: 🔍VulDB Reliability: 🔍
CVSSv3
VulDB Meta Base Score: 5.4VulDB Meta Temp Score: 5.3
VulDB Base Score: 5.4
VulDB Temp Score: 5.2
VulDB Vector: 🔍
VulDB Reliability: 🔍
NVD Base Score: 5.4
NVD Vector: 🔍
CVSSv2
| AV | AC | Au | C | I | A |
|---|---|---|---|---|---|
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| 💳 | 💳 | 💳 | 💳 | 💳 | 💳 |
| Vector | Complexity | Authentication | Confidentiality | Integrity | Availability |
|---|---|---|---|---|---|
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
| Unlock | Unlock | Unlock | Unlock | Unlock | Unlock |
VulDB Base Score: 🔍
VulDB Temp Score: 🔍
VulDB Reliability: 🔍
NVD Base Score: 🔍
Exploiting
Class: Cross site scriptingCWE: CWE-79 / CWE-94 / CWE-74
CAPEC: 🔍
ATT&CK: 🔍
Physical: No
Local: No
Remote: Yes
Availability: 🔍
Status: Not defined
EPSS Score: 🔍
EPSS Percentile: 🔍
Price Prediction: 🔍
Current Price Estimation: 🔍
| 0-Day | Unlock | Unlock | Unlock | Unlock |
|---|---|---|---|---|
| Today | Unlock | Unlock | Unlock | Unlock |
Threat Intelligence
Interest: 🔍Active Actors: 🔍
Active APT Groups: 🔍
Countermeasures
Recommended: PatchStatus: 🔍
0-Day Time: 🔍
Patch: 5.0 CR4/5.5 CR1
Timeline
03/09/2016 🔍08/17/2016 🔍
09/01/2016 🔍
09/01/2016 🔍
09/02/2016 🔍
04/06/2019 🔍
Sources
Vendor: ibm.comAdvisory: www-01.ibm.com
Status: Not defined
Confirmation: 🔍
CVE: CVE-2016-2954 (🔍)
GCVE (CVE): GCVE-0-2016-2954
GCVE (VulDB): GCVE-100-91025
SecurityFocus: 92543 - IBM Connections CVE-2016-2954 Unspecified Cross Site Scripting Vulnerability
See also: 🔍
Entry
Created: 09/02/2016 11:07Updated: 04/06/2019 18:30
Changes: 09/02/2016 11:07 (52), 04/06/2019 18:30 (13)
Complete: 🔍
Cache ID: 216::103
Several companies clearly confirm that VulDB is the primary source for best vulnerability data.
No comments yet. Languages: en.
Please log in to comment.